10/14/2003 98-R-1012
FROM: Susan Price-Livingston, Research Attorney
RE: Elimination of Medicaid Prescription Co-pays
You asked for a brief summary of the reasons why the legislature voted to eliminate Medicaid prescription co-pays.
In November 1997 the Department of Social Services (DSS) implemented a $1 co-pay for all prescriptions, refills, and over-the-counter medications covered by Medicaid. (Medicaid is a state-federal public insurance program that pays the health care costs of very low-income families and individuals.) This was part of its comprehensive program to reduce pharmacy benefit costs as mandated by PA 95-351 and PA 97-2, June 18 Special Session. In essence, pharmacies began charging Medicaid recipients $1 each time they filled a prescription or bought covered over-the-counter products. Consistent with federal law, DSS notified pharmacists that they had to dispense medications to eligible beneficiaries who were unable to pay the $1.
During the February 1998 session, the Human Services Committee favorably reported a bill (HB 5093) that prohibited such prescription co-pays (and apparently barred DSS from using other methods of cost sharing as well). The Medicaid prescription co-pay ban was ultimately enacted as Section 22 of PA 98-239. That bill leaves intact DSS' authority to implement other forms of cost sharing to the extent permitted by federal Medicaid regulations.
During the session, testimony presented jointly to the Human Services and Public Health Committees, as well as to the Appropriations Committee overwhelmingly favored the elimination of the prescription co-pays. Supporters of the ban included the Office of Protection and Advocacy for Persons with Disabilities, the Latino and Puerto Rican Affairs Commission, the Connecticut Association of Health Directors, the Alliance for the Mentally Ill, the National Association for Social Workers (Connecticut Chapter), New Haven Legal Assistance, many HIV/AIDS advocacy groups, and a number of individuals receiving Medicaid benefits.
A primary argument made was that prescription co-pays unduly burden poor people with chronic debilitating diseases like HIV/AIDS and mental illness, who must take many different medications on an ongoing basis. Representative McDonald gave the example of the significant costs incurred by people with some types of mental illness, for whom doctors will prescribe only few days worth of medication at a time and thus must pay several co-pays every week. Others noted that the rule disproportionately effected Hispanics, African Americans, women, and the elderly.
It was also suggested that co-pays created a barrier to ongoing treatment for many low-income people, who stopped taking medication or reduced the prescribed dosage because they could not afford the co-pays on their limited budgets. Several advocates expressed the view that the state's medical costs would actually increase in the long run because people whose conditions could have been controlled with medication would forego such treatment and become sicker or require expensive hospitalization.
Several medical assistance recipients and advocates also reported that some pharmacists were refusing to fill prescriptions for those who could not afford the co-pay, and that other eligible recipients had been embarrassed, humiliated, and treated rudely when they told a pharmacist that they could not pay the prescription co-pay.
SPL:lc